Skip to content

Clinical trials

Phase 4 trials in Kazakhstan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 4 Country / region: Kazakhstan Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20102
20111
20121
20162
20174
20182
20202
20231
20242
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Active, not recruiting2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Yuria-Pharm3
Kazakh Eye Research Institute2
Kazakhstan's Medical University "KSPH"2
Materia Medica Holding2
Nazarbayev University2
Sanofi2
Università Vita-Salute San Raffaele2
Catalysis SL1
Dr. Reddy's Laboratories Limited1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 23
Anxiety Disorders1
Arthritis, Rheumatoid1
Atherosclerosis1
Burns1
Carcinoma, Non-Small-Cell Lung1
Coronary Artery Disease1
Critical Illness1
Diabetes Mellitus, Type 11
Dry Eye Syndromes1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.